On April 23, the Acting Attorney General of the U.S. Department of Justice issued a final order moving certain marijuana-related products from Schedule I to Schedule III under the Controlled Substances Act. The move is narrowly focused, but it is a meaningful shift in federal treatment of medical marijuana.









